INO vs AMGN: Which Stock is Better?
Side-by-side comparison of Inovio Pharmaceuticals Inc and Amgen Inc in 2026
INO
Inovio Pharmaceuticals Inc
$1.19
AMGN
Amgen Inc
$348.22
Key Metrics Comparison
| Metric | INO | AMGN | Winner |
|---|---|---|---|
| Market Cap | $90.57M | $189.19B | AMGN |
| P/E Ratio | N/A | 24.70 | AMGN |
| EPS (TTM) | $N/A | $14.21 | AMGN |
| Revenue Growth | -1.0% | 0.1% | AMGN |
| Gross Margin | -82857.4% | 70.8% | AMGN |
Analyze INO
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INO or AMGN a better investment?
Comparing INO and AMGN: Inovio Pharmaceuticals Inc has a market cap of $90.57M while Amgen Inc has $189.19B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INO and AMGN?
INO (Inovio Pharmaceuticals Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INO or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: INO or AMGN?
AMGN has higher revenue growth at 0.1% vs -1.0% for INO.
Which company is more profitable: INO or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to -82857.4% for INO.
Which is the larger company: INO or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $189.19B compared to $90.57M for INO.
Should I buy INO or AMGN in 2026?
Both INO and AMGN have investment merit. INO trades at $1.19 while AMGN trades at $348.22. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INO and AMGN stock?
Key differences: Market Cap ($90.57M vs $189.19B), P/E Ratio (N/A vs 24.7x), Revenue Growth (-1.0% vs 0.1%), Gross Margin (-82857.4% vs 70.8%).